recent
amilorid
shown
potent
suppress
coxsackieviru
replic
current
studi
investig
whether
amilorid
could
also
exhibit
antivir
activ
footandmouth
diseas
viru
fmdv
belong
famili
picornavirida
found
amilorid
exert
antivir
activ
dosedepend
manner
two
strain
fmdv
cell
slight
cytotox
besid
amilorid
inhibit
attach
entri
fmdv
cell
prevent
earli
viral
replic
data
impli
amilorid
could
promis
candid
research
potenti
antivir
drug
fmdv
infect
footandmouth
diseas
fmd
one
viral
diseas
caus
fmd
viru
fmdv
belong
famili
picornavirida
genu
aphthoviru
becom
major
threat
global
livestock
industri
owe
high
infect
presenc
variou
fmdv
serotyp
therefor
consider
interest
develop
effect
measur
prevent
control
fmd
current
vaccin
primari
method
prevent
fmd
howev
sever
factor
limit
use
fmd
vaccin
includ
slow
antibodi
product
low
antibodi
level
short
durat
antibodi
persist
poor
immun
respons
lack
effect
control
measur
underlin
import
research
new
antivir
amilorid
known
drug
blocker
cellular
na
h
exchang
epitheli
na
channel
current
amilorid
deriv
use
potassiumspar
diuret
treatment
hypertens
prevent
hypokalemia
associ
congest
heart
failur
recent
year
increas
interest
explor
antivir
activ
amilorid
owe
low
toxic
previou
studi
demonstr
amilorid
inhibit
coxsackieviru
replic
infect
hela
cell
directli
affect
viral
replic
releas
besid
amilorid
deriv
n
nhexamethylen
amilorid
hma
also
note
inhibit
ion
channel
form
protein
human
immunodefici
viru
hepat
c
viru
coronaviru
dengu
virus
report
amilorid
nethylnisopropyl
amilorid
eipa
benzamil
inhibit
replic
human
rhinoviru
infect
cell
antivir
activ
unlik
due
inhibit
cellular
nah
exchang
epitheli
na
channel
howev
remain
unknown
whether
amilorid
exert
inhibitori
effect
fmdv
infect
present
studi
demonstr
antivir
activ
amilorid
fmdv
investig
effect
amilorid
differ
stage
fmdv
infect
result
obtain
indic
amilorid
might
potenti
antivir
agent
reduc
fmdv
infect
cell
cultur
dulbecco
modifi
eagl
medium
dmem
provid
unitsml
penicillin
streptomycin
supplement
vv
vv
fetal
bovin
serum
fb
growth
medium
mainten
medium
respect
fmdv
includ
two
differ
strain
propag
cell
cultur
dmem
supplement
fb
amilorid
fig
purchas
mce
medchemexpress
dissolv
dmso
investig
cytotox
amilorid
cell
http
receiv
februari
receiv
revis
form
juli
accept
juli
seed
cultur
plate
incub
follow
day
medium
remov
plate
replac
medium
contain
serial
dilut
amilorid
rang
cytotox
determin
h
treatment
use
mt
assay
abcam
absorb
formazan
product
measur
nm
use
micropl
reader
thermo
fisher
scientif
waltham
massachusett
usa
antivir
activ
amilorid
determin
mt
assay
base
cytopath
effect
cpe
induc
fmdv
infect
previous
describ
one
day
infect
cell
well
seed
cultur
plate
incub
co
atmospher
subsequ
cell
infect
fmdv
moi
h
unbound
virus
remov
wash
dmem
serial
dilut
amilorid
concentr
rang
ad
confluent
cell
cultur
plate
incub
co
atmospher
h
appropri
cpe
achiev
absorb
determin
nm
use
elisa
reader
thermo
fisher
scientif
waltham
massachusett
usa
antivir
activ
present
percentag
control
determin
use
follow
formula
antivir
activ
odtestsampleodviruscontrol
odcellcontrolodviru
control
odtestsampl
absorb
measur
concentr
compound
fmdv
infect
cell
odviruscontrol
absorb
measur
control
untreat
fmdvinfect
cell
odcellcontrol
absorb
measur
control
untreat
uninfect
cell
concentr
requir
reduc
virusinduc
cytopathogen
control
valu
ec
valu
calcul
use
graphpad
graphpad
softwar
evalu
antivir
efficaci
amilorid
cultur
supernat
collect
viral
mrna
protein
express
level
analyz
test
broadspectrum
antivir
effect
amilorid
subconflu
cell
infect
anoth
fmdv
strain
incub
drug
describ
earlier
assess
effect
amilorid
attach
fmdv
cell
cell
treat
mixtur
amilorid
fmdv
moi
h
allow
virus
bind
surfac
cell
enter
cell
control
infect
cell
without
amilorid
treatment
employ
remov
amilorid
unbound
virus
wash
dmem
cell
subject
three
freezethaw
cycl
measur
viral
mrna
level
evalu
whether
amilorid
affect
entri
fmdv
cell
cell
infect
fmdv
moi
h
remov
unbound
virus
wash
dmem
cell
incub
amilorid
h
antivir
efficaci
determin
analyz
viral
mrna
level
control
infect
cell
without
amilorid
treatment
employ
timeofaddit
toa
assay
design
determin
mechan
action
amilorid
brief
amilorid
final
concentr
ad
cell
h
h
fmdv
infect
incub
h
incub
qpcr
perform
use
sybr
premix
ex
ii
tli
rnaseh
plu
takara
dalian
china
ascertain
level
fmdv
mrna
total
rna
extract
use
trizol
reagent
invitrogen
accord
manufactur
instruct
rt
reaction
perform
total
rna
use
rt
reagent
kit
contain
gdna
eras
takara
dalian
china
realtim
pcr
conduct
sybr
premix
ex
taqtm
ii
tli
rnaseh
plu
takara
dalian
china
presenc
specif
primer
includ
fmdv
fmdv
agil
technolog
stratagen
instrument
agil
usa
rel
mrna
express
level
calcul
method
use
intern
control
normal
mean
mrna
level
mocktreat
group
set
collect
cell
lyse
cold
pierc
ripa
buffer
thermo
fisher
scientif
min
cell
lysat
fraction
use
bioruptor
sonic
min
puls
indic
cell
treat
amilorid
data
repres
mean
sd
three
independ
experi
p
compar
control
group
lysat
centrifug
min
protein
concentr
confirm
use
bca
assay
thermo
fisher
scientif
averag
amount
protein
mix
load
buffer
trishcl
ph
glycerol
sd
bromophenol
blue
boil
min
electrophoresi
protein
transfer
pvdf
membran
use
standard
protocol
membran
block
bsa
h
primari
antibodi
polyclon
antibodi
gift
haixu
zheng
oienat
footandmouth
diseas
refer
laboratori
abcam
use
detect
band
protein
blot
thereaft
membran
wash
tbst
tb
contain
incub
h
hrpconjug
secondari
antibodi
abcam
band
visual
enhanc
chemiluminesc
ecl
kit
invitrogen
expos
radiographi
film
monolay
cell
grown
plate
contain
fb
infect
fmdv
moi
h
adsorpt
supernat
discard
replac
serial
dilut
amilorid
rang
cell
incub
co
atmospher
h
immunofluoresc
assay
ifa
conduct
describ
previous
minor
modif
cell
fix
paraformaldehyd
min
wash
pb
rabbit
hyperimmun
serum
type
fmdv
kindli
provid
guangq
zhou
oienat
footandmouth
diseas
refer
laboratori
ad
mixtur
incub
overnight
wash
thoroughli
pb
elimin
unbound
antibodi
afterward
cell
treat
goat
antirabbit
igg
h
l
zsgb
beij
china
h
wash
pb
five
time
photograph
invert
fluoresc
microscop
signific
differ
determin
ttest
oneway
anova
use
spss
softwar
follow
tukey
posthoc
multipl
comparison
test
data
report
mean
sd
n
valu
p
consid
statist
signific
highli
infecti
publicli
polit
highprofil
diseas
fmd
affect
million
clovenhoov
anim
attract
global
concern
major
problem
control
fmd
outbreak
normal
diseasefre
countri
delay
onset
immun
follow
emerg
vaccin
antivir
agent
potenti
provid
vital
protect
delay
amilorid
report
exhibit
antivir
activ
howev
best
knowledg
previou
definit
studi
antivir
activ
amilorid
fmdv
belong
famili
picornavirida
analysi
cytotox
amilorid
reveal
amilorid
littl
effect
cell
viabil
treatment
amilorid
induc
mild
cytotox
host
cell
concentr
fig
addit
concentr
differ
cell
morpholog
found
amiloridetr
mocktreat
cell
data
shown
cc
amilorid
estim
graphpad
softwar
investig
antivir
protect
cell
cpe
caus
fmdv
infect
serial
dilut
rang
amilorid
use
treatment
amilorid
signific
protect
cell
cpe
p
fig
concentr
amilorid
found
provid
effect
protect
cell
infect
fmdv
fig
confirm
inhibitori
effect
amilorid
fmdv
replic
cell
realtim
pcr
western
blot
analysi
ifa
perform
mean
rel
mrna
load
cell
treat
amilorid
respect
mean
rel
mrna
load
mocktreat
cell
set
fig
consist
result
fmdv
protein
significantli
suppress
follow
treatment
amilorid
fig
regard
ifa
control
cell
treat
amilorid
gener
strong
fluoresc
signal
h
postinfect
wherea
cell
treat
amilorid
show
reduc
fluoresc
signal
fig
therefor
amilorid
repres
novel
antivir
molecul
fmdv
interestingli
amilorid
exhibit
antivir
activ
differ
strain
fmdv
effect
dose
amilorid
type
fmdv
fig
shown
tabl
indic
cell
treat
amilorid
valu
repres
mean
standard
deviat
three
independ
experi
p
compar
control
group
approxim
twofold
higher
indic
amilorid
could
serv
broadspectrum
drug
treat
fmdv
infect
investig
action
amilorid
fmdv
viral
attach
entri
assay
perform
determin
stage
viral
lifecycl
affect
amilorid
treatment
result
viral
attach
test
reveal
mean
rel
mrna
level
cell
treat
amilorid
respect
mean
rel
mrna
level
mocktreat
cell
set
fig
find
viral
entri
experi
demonstr
mean
rel
mrna
level
cell
treat
amilorid
respect
mean
rel
mrna
level
mocktreat
cell
set
fig
thu
signific
differ
rel
level
viral
mrna
observ
drugtreat
mocktreat
cell
indic
amilorid
effect
fmdv
attach
entri
cell
identifi
stage
viral
replic
inhibit
amilorid
toa
experi
perform
cell
incub
amilorid
h
h
fmdv
infect
qpcr
western
blot
assay
conduct
h
postinfect
determin
rel
mrna
level
protein
infect
untreat
cell
fig
viral
mrna
level
notic
inhibit
amilorid
treatment
h
postinfect
mean
rel
mrna
level
cell
treat
amilorid
h
respect
mean
rel
mrna
level
mocktreat
cell
set
fig
similarli
viral
protein
express
also
low
even
amilorid
treatment
h
postinfect
fig
howev
neglig
inhibitori
effect
observ
amilorid
treatment
h
postinfect
indic
amilorid
block
fmdv
replic
earli
stage
viral
infect
interestingli
previou
studi
reveal
amilorid
could
inhibit
genom
replic
act
competit
inhibitor
inhibit
enzymat
activ
cell
cultur
affect
vpgpupu
synthesi
rna
elong
particular
amilorid
could
compet
nucleosid
triphosph
mg
molecular
mechan
action
amilorid
fmdv
examin
detail
report
amilorid
analog
differ
content
inhibitori
activ
thu
interest
investig
compar
efficaci
amilorid
analog
eipa
n
ndimethyl
amilorid
hma
fmdv
recent
investig
protect
effect
amilorid
fmdvchalleng
suckl
mous
model
base
antifmdv
replic
activ
amilorid
vitro
find
reveal
amilorid
show
better
protect
compar
dmsotreat
group
day
postinfect
nevertheless
larger
studi
requir
determin
signific
differ
surviv
rate
conclus
fmdv
infect
cell
inhibit
dosedepend
manner
amilorid
treatment
vitro
result
show
amilorid
could
promis
novel
antivir
agent
use
earli
stage
viral
infect
vaccineinduc
immun
respons
trigger
howev
studi
requir
determin
exact
mechan
action
amilorid
